Because the present study regimen caused intestinal toxicity [8], we investigated the possibility that the extent of decline in serum LCN2 and MMP9 levels might also, in susceptible individuals, predict treatment-induced enteropathy, clinically presenting as diarrhea. This evidence concerns the gene LCN2 and Abnormal intestine morphology.